EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Driving factors for beta-lactam resistance gene amplification during de novo resistance evolution in E. coli

Luyuan Nong, Xinwei Liu, Xinyu Wang, Wim de Leeuw, Martijs Jonker, Stanley Brul iD, Benno Ter Kuile iD

Antimicrobial Agents and Chemotherapy · 2025

DOI: 10.1128/aac.00441-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Luyuan Nong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Swammerdam Institute of Life Sciences, University of Amsterdam, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Escherichia coli, beta-Lactam Resistance, beta-Lactamases, Gene Amplification. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Long-term exposure of E. coli to non-lethal step-wise increasing concentrations of beta-lactam antibiotics induces high levels of resistance that can be accompanied by amplification of a chromosomal fragment around the ampC gene. We compared the amplification of the ampC fragment in the wild type, an ampC knockout mutant, a mutant in which the ampC gene was replaced by a tetracycline resistance gene tet(B ), and a strain in which the ampC has been translocated. When ampC was removed, no amplification occurred at the original ampC location, but DNA fragments were amplified around the genes coding for efflux pump AcrAB and the multiple antibiotic resistance operon MarRAB. When tet(B ) replaced ampC , exposure to tetracycline induced amplification of comparable fragments, while exposure to amoxicillin induced duplication of a larger fragment elsewhere. When ampC was translocated, a fragment around it at the new location was amplified. The importance of the presence but not of the location within the chromosome of the resistance genes for the amplification process indicates that the mechanisms are neither gene nor location specific. Without the relatively efficient resistance gene ampC , duplication and amplification occur around acrAB and marRAB that code for amoxicillin and tetracycline resistance factors. These duplications and amplifications are prevented by ampC amplification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Escherichia colibeta-Lactam Resistancebeta-LactamasesGene Amplificationbeta-LactamsAnti-Bacterial AgentsBacterial ProteinsEscherichia coli ProteinsMicrobial Sensitivity TestsEvolution, MolecularAmoxicillinTetracycline

Stichwörter der Autor:innen

ampCbeta-lactam antibioticsgene amplificationgene translocation

Substanzen

beta-LactamasesAmpC beta-lactamasesAnti-Bacterial AgentsBacterial ProteinsEscherichia coli Proteinsbeta-LactamsAmoxicillinTetracycline

Autor:innen und Institutionen

  • Swammerdam Institute of Life Sciences, University of Amsterdam, Amsterdam, the Netherlands.

ORCID-Profile: Stanley Brul, Benno Ter Kuile

Zitieren

APA

Nong, L., Liu, X., Wang, X., de Leeuw, W., Jonker, M., Brul, S., & Ter Kuile, B. (2025). Driving factors for beta-lactam resistance gene amplification during de novo resistance evolution in E. coli. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00441-25

Vancouver

Nong L, Liu X, Wang X, de Leeuw W, Jonker M, Brul S, et al. Driving factors for beta-lactam resistance gene amplification during de novo resistance evolution in E. coli. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.00441-25

BibTeX
@article{Nong2025,
  author = {Nong, Luyuan and Liu, Xinwei and Wang, Xinyu and de Leeuw, Wim and Jonker, Martijs and Brul, Stanley and Ter Kuile, Benno},
  title = {Driving factors for beta-lactam resistance gene amplification during de novo resistance evolution in E. coli},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2025},
  doi = {10.1128/aac.00441-25}
}
Kostenlos starten →